Hoffman Michael B bought 5,000,000 shares of Annovis Bio, Inc. at $1.00 for $5.00M on Nov 6, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$5,000,000Shares × reported price
Shares traded
5,000,000Common Stock
Price per share
$1.00Reported price. Read footnotes for ranges.
% of reported position traded
148.59%This security and ownership context
Holdings after
8,364,883Direct
Trade date
Nov 6, 2026Buy
Filed
Nov 6, 2026, 4:30 PM ET0-day reporting delay
Accession
0001104659-26-123905Code P · Transaction 394892
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 3,364,883 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 6, 2026Buy5,000,000$0.00$0Trade 394893
2 transaction rows in this filing. Joint filers share the same rows.

ANVS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ANVS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 13, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: The 5,000,000 shares of Common Stock and 5,000,000 warrants described in Table I and Table II, respectively, were acquired for a combined price of $1.00 per share. F2: The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.